Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.39 |
| ▸ | LPL | P06858 | 12/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | SNCA | P37840 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL907049 | 0.90 | KDM4E (0.40) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL5137400 | 0.78 | MAPT (0.49) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL17113535 | 0.78 | IRAK4 (0.39) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL17113584 | 0.78 | LPL (0.41) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL31752127 | 0.77 | IDO1 (0.39) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL30928610 | 0.77 | IDO1 (0.39) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL31467299 | 0.76 | ESR2 (0.40) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL31394882 | 0.76 | LPL (0.43) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL23638441 | 0.75 | FFAR1 (0.39) | IRAK4LPLLIPGIDO1TDO2 | |
| SCHEMBL23633173 | 0.75 | LPL (0.36) | IRAK4LPLLIPGIDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024255765-A1 | NOVEL COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | NUPHASE THERAPEUTICS (HANGZHOU) LIMITED., CO. (CN) | 2024-12-19 | — | — | WO | disclosed |